Comprehensive Portfolio Management LLC bought a new position in Walgreens Boots Alliance Inc (NASDAQ:WBA) during the third quarter, Holdings Channel reports. The firm bought 2,940 shares of the pharmacy operator’s stock, valued at approximately $214,000.

Several other large investors have also recently bought and sold shares of the stock. Hugh Johnson Advisors LLC lifted its position in shares of Walgreens Boots Alliance by 11.0% in the second quarter. Hugh Johnson Advisors LLC now owns 7,801 shares of the pharmacy operator’s stock worth $468,000 after buying an additional 773 shares in the last quarter. World Asset Management Inc lifted its position in shares of Walgreens Boots Alliance by 1.4% in the second quarter. World Asset Management Inc now owns 58,572 shares of the pharmacy operator’s stock worth $3,515,000 after buying an additional 807 shares in the last quarter. BDO Wealth Advisors LLC lifted its position in shares of Walgreens Boots Alliance by 11.1% in the second quarter. BDO Wealth Advisors LLC now owns 8,411 shares of the pharmacy operator’s stock worth $505,000 after buying an additional 837 shares in the last quarter. Sumitomo Life Insurance Co. lifted its position in shares of Walgreens Boots Alliance by 4.5% in the second quarter. Sumitomo Life Insurance Co. now owns 19,814 shares of the pharmacy operator’s stock worth $1,189,000 after buying an additional 850 shares in the last quarter. Finally, Buckley Wealth Management LLC lifted its position in shares of Walgreens Boots Alliance by 10.4% in the second quarter. Buckley Wealth Management LLC now owns 9,015 shares of the pharmacy operator’s stock worth $541,000 after buying an additional 850 shares in the last quarter. Institutional investors own 61.92% of the company’s stock.

A number of brokerages have issued reports on WBA. Robert W. Baird downgraded Walgreens Boots Alliance from an “outperform” rating to a “neutral” rating and set a $80.00 price objective on the stock. in a research report on Friday, June 29th. BidaskClub upgraded Walgreens Boots Alliance from a “hold” rating to a “buy” rating in a research report on Wednesday, September 12th. Zacks Investment Research upgraded Walgreens Boots Alliance from a “hold” rating to a “buy” rating and set a $81.00 price objective on the stock in a research report on Tuesday, September 25th. SunTrust Banks upped their price objective on Walgreens Boots Alliance to $75.00 and gave the company a “hold” rating in a research report on Friday. Finally, ValuEngine upgraded Walgreens Boots Alliance from a “strong sell” rating to a “sell” rating in a research report on Friday, September 21st. One investment analyst has rated the stock with a sell rating, eleven have assigned a hold rating, seven have assigned a buy rating and two have assigned a strong buy rating to the company’s stock. The company has an average rating of “Hold” and a consensus target price of $76.94.

In other Walgreens Boots Alliance news, insider Stefano Pessina bought 1,697,438 shares of the business’s stock in a transaction dated Monday, July 16th. The shares were purchased at an average price of $63.92 per share, with a total value of $108,500,236.96. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director William C. Foote sold 2,736 shares of the company’s stock in a transaction that occurred on Thursday, August 2nd. The shares were sold at an average price of $65.99, for a total value of $180,548.64. Following the transaction, the director now directly owns 10,943 shares in the company, valued at approximately $722,128.57. The disclosure for this sale can be found here. Corporate insiders own 14.80% of the company’s stock.

WBA opened at $73.50 on Friday. The company has a market cap of $72.35 billion, a PE ratio of 14.41, a price-to-earnings-growth ratio of 1.11 and a beta of 1.04. Walgreens Boots Alliance Inc has a one year low of $59.07 and a one year high of $80.68. The company has a current ratio of 0.93, a quick ratio of 0.47 and a debt-to-equity ratio of 0.44.

Walgreens Boots Alliance (NASDAQ:WBA) last released its earnings results on Thursday, October 11th. The pharmacy operator reported $1.48 EPS for the quarter, beating analysts’ consensus estimates of $1.45 by $0.03. The firm had revenue of $33.44 billion for the quarter, compared to analysts’ expectations of $33.64 billion. Walgreens Boots Alliance had a return on equity of 21.22% and a net margin of 3.36%. As a group, equities research analysts predict that Walgreens Boots Alliance Inc will post 5.98 earnings per share for the current year.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of general merchandise, including non-prescription drugs, beauty products, photo finishing, seasonal merchandise, greeting cards, and convenience foods through its retail drugstores and convenient care clinics.

Featured Article: Why is the conference call important?

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance Inc (NASDAQ:WBA).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.